Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
ALLLIFE CAR-NK CD19 by Allife Medical Science and Technology for B-Cell Leukemia: Likelihood of Approval
ALLLIFE CAR-NK CD19 is under clinical development by Allife Medical Science and Technology and currently in Phase II for B-Cell...